19 Jun'26 Portfolio
Leaning into financials
Vish (Hunting Alphas)
Marvell: Set To Win From Hyperscalers' Custom Chip Programs (Archive)
Marvell is primed for explosive custom AI chip growth, despite premium valuation risks.
Astronics: On The Cusp Of A Production And Upgradation Upcycle (Archive, Full Access)
Astronics rides a powerful aircraft production, retrofit, and premium cabin systems upcycle tailwind.
Nova: Riding A Trillion‑Dollar Fab Capex Wave
Niche Metrology Leader With Outsized Upside In The WFE Supercycle
12 Jun'26 Portfolio
A very diversified global portfolio that is underweight technology
Novo Nordisk: Wegovy Pill Is Encouraging But Still Not Enough To Make Me Buy (Archive)
Wegovy pill expands US obesity share, but cash flow limits and GLP‑1 competition constrain upside.
AMD: The Market Is Still Underpricing Its AI CPU Super Cycle (Archive, Full Access)
AMD’s agentic-AI-driven server CPU and GPU surge is still mispriced by markets.